Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/25 16:53 | 4/29/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 5 | S.d | -1,856 | 61.11 | 0 | -30 | 19 | D | |||||||||||||||
5/1/25 16:52 | 4/29/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Mazabraud Yann | MA | O | EVP,Head | 3 | S.d | -5,383 | 54.10 | 0 | -99 | 40 | D | |||||||||||||||
3/24/25 17:47 | 3/21/25 | RYTM | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | 2 | S.d | -55 | 56.17 | 0 | -1 | 3 | D | |||||||||||||||
2/19/25 21:50 | 2/19/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Smith Hunter C | MA | O | CFO | 4 | S.d | -343 | 57.80 | 0 | -6 | 110 | D | |||||||||||||||
2/19/25 21:49 | 2/19/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Shulman Joseph | MA | O | Chief Te | 4 | S.d | -219 | 57.93 | 0 | -4 | 9 | D | |||||||||||||||
2/19/25 21:48 | 2/19/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | 2 | S.d | -820 | 57.89 | 0 | -14 | 201 | D | |||||||||||||||
2/19/25 21:46 | 2/19/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Lee Jennifer Kayden | MA | O | EVP,Head | 5 | S.dm | -866 | 58.59 | 0 | -15 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |